Aberrant methylation patterns at the two-cell stage as an indicator of early developmental failure

Mol Reprod Dev. 2002 Nov;63(3):329-34. doi: 10.1002/mrd.90016.

Abstract

The fertilized mouse egg actively demethylates the paternal genome within a few hours after fertilization, whereas the maternal genome is only passively demethylated by a replication-dependent mechanism after the two-cell stage. This evolutionarily conserved assymetry in the early diploid mammalian embryo may have a role in methylation reprogramming of the two very different sets of sperm and egg chromatin for somatic development and formation of totipotent cells. Immunofluorescence staining with an antibody against 5-methylcytosine (MeC) showed that the incidence of abnormal methylation patterns differs between mouse two-cell embryos from superovulated females, nonsuperovulated matings, and in vitro fertilization (IVF). It also depends on embryo culture conditions and genetic background. In general, there was a good correlation with the number of embryos (from the same experiment) which did not develop in vitro up to the blastocyst stage. Thus, aberrant genome-wide DNA methylation in early embryos may be an important mechanism contributing to the high incidence of developmental failure in mammals. Similar to the situation in abnormally methylated embryos from nuclear transfer, it may cause a high incidence of pregnancy loss and abnormal phenotypes.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acetaldehyde / pharmacology
  • Animals
  • Cleavage Stage, Ovum / metabolism*
  • Cleavage Stage, Ovum / pathology
  • DNA Methylation* / drug effects
  • Enzyme Inhibitors / pharmacology
  • Fertilization in Vitro / adverse effects
  • Fluorescent Antibody Technique
  • Mice
  • Superovulation

Substances

  • Enzyme Inhibitors
  • Acetaldehyde